Stern Pinball Announces New James Bond 007 Pinball Machines
22.9.2022 17:00:00 EEST | Business Wire | Press release
Stern Pinball, Inc. launches a new line of pinball machines celebrating the iconic, genre-defining James Bond films. The James Bond 007 cornerstone series features the original 007 actor, Sean Connery, available in Pro Edition, Premium Edition, and Limited Edition (LE). Stern Pinball will also release a special James Bond 007 60th Anniversary Limited Edition pinball machine featuring all six James Bond actors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220922005077/en/
James Bond 007 Pinball Pro Edition (Photo: Business Wire)
In Dr. No (1962) Sean Connery propelled 007 into the cultural zeitgeist, bringing the legendary literary figure to life through adrenalized action sequences, ground-breaking gadgets and effects, memorable characters, and timeless villains.
Stern’s James Bond 007 cornerstone pinball machine will highlight film footage and iconic music from the films that built the 007 legend: Dr. No, From Russia With Love (1963), Goldfinger (1964), Thunderball (1965), You Only Live Twice (1967), and Diamonds Are Forever (1971). Players are immersed into the world of espionage in this action-packed pinball experience, tackling assignments, teaming up with key allies, and stopping SPECTRE’s villainous schemes.
Gather gadgets from Q Branch as pinballs get ejected through the roof of a custom sculpted Aston Martin DB5. Break through the Osato Chemicals drop targets to battle SPECTRE at the Bird 1 rocket base. And hold your breath on the gravity defying, magnetic jetpack as it transports pinballs across the playfield.
James Bond 007 pinball machines include Stern’s award-winning Insider Connected™ system, which enables players to interact with the game and a global network of players in a variety of ways. Through Insider Connected, players can track progress, earn new game-specific achievements, engage with the player community, and participate in promotions and Challenge Quests. Insider Connected also provides an operator-focused toolset to drive location play through Location Leaderboards, build player loyalty, analyze performance, make adjustments remotely, and maintain the machines. Registration for Insider Connected is available at insider.sternpinball.com/.
Limited to 1,000 machines globally, the highly collectible cornerstone Limited Edition includes an exclusive full-color mirrored backglass inspired by Thunderball, masterfully adapted cabinet artwork, custom high gloss and powder-coated pinball armor, a custom designer-autographed bottom arch, exclusive inside art blades, upgraded audio system, anti-reflection pinball playfield glass, shaker motor, a sequentially numbered plaque, and a Certificate of Authenticity signed by Stern Chairman Gary Stern and President Seth Davis.
Stern’s James Bond 007 60th Anniversary Limited Edition pinball machines will immerse players in the history of 007. Limited to 500 machines globally, the highly collectible 60th Anniversary Limited Edition offers players a retro-inspired playfield packed with exciting mechanical action. Control the chaos from Oddjob’s kinetic spinning disc hat, survive tactical precision shots against 10 drop targets, escape SPECTRE’s evil henchmen navigating pinballs through 4 fast-flowing optical spinners, learn assignments through an in-playfield LCD screen, and rack up high scores on classic-style score reels.
“James Bond is as timeless as pinball. Partnering with EON Productions/Danjaq, MGM Studios and Aston Martin, we created a pinball adventure capturing the suspense, action, and humor from this beloved film series,” said Gary Stern, Chairman and CEO. “Get connected today and become a legend.”
Fittingly, the new James Bond 007 pinball machines will be on show for the first time to media and public in London. On September 26th the games will be on display and available to play as part of the Bond-themed Christie’s Late, a public event celebrating the forthcoming Christie’s Sixty Years of James Bond Charity Auction. Shortly after, they will be a part of the James Bond at 60 weekend at the British Film Institute on the South Bank, September 30th-October 2nd.
Pricing and Availability:
Manufacturer’s Suggested Retail Price (“MSRP”)*:
*MSRP for sales to USA end-users, before any VAT, GST, Sales Tax, Duties, or other taxes.
Pro Edition: $US 6,999
Premium Edition: $US 9,699
Limited Edition: $US 12,999
60th Anniversary Limited Edition: CALL FOR PRICE
James Bond 007 pinball machines and accessories are available now through authorized Stern Pinball distributors and dealers around the world. Pro and Premium Editions will also be available at 007Store.com.
About Stern Pinball, Inc.
Stern Pinball, Inc. is a global lifestyle brand based on the iconic and outrageously fun modern American game of pinball. Headquartered minutes from Chicago’s O’Hare International Airport in the heart of North America, the company creates, designs, engineers, manufactures, markets, and distributes a full line of technologically advanced terrestrial and digital pinball games, parts, accessories, and merchandise. Stern Pinball serves digital, consumer, commercial, and corporate markets around the globe.
Recent Stern Pinball titles include Rush, Godzilla, The Mandalorian, Led Zeppelin, Avengers: Infinity Quest, Teenage Mutant Ninja Turtles, Stranger Things, Elvira’s House of Horrors, Jurassic Park, Black Knight: Sword of Rage, The Munsters, The Beatles, Deadpool, Iron Maiden, Guardians of the Galaxy, Star Wars, Aerosmith, Ghostbusters, KISS, Metallica, Game of Thrones, The Walking Dead, Star Trek, AC/DC, Batman, and Spider-Man. A broad range of players enjoy Stern Pinball’s games from professional pinball players who compete in high-stakes competitions around the globe to novice players who are discovering the allure of the silver ball for the first time. To join the fun and learn more, please visit www.sternpinball.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005077/en/
Contact information
Zach Sharpe
zach.sharpe@sternpinball.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 09:07:00 EET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 09:00:00 EET | Press release
Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers across Europe to bring advanced proton treatment to their patients. “With both FDA clearance and CE Marking now in hand, the MEVION S250-FIT is
Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 08:30:00 EET | Press release
Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2024, › Free Cash Flow of EUR 824.2 million, up 3.9% organically and up 2.6% at constant currency, and cash conversion of 107%2, › Adjusted net
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 08:00:00 EET | Press release
Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat in a mouse model in Sandhoff disease, a form of GM2 gangliosidosis with no approved treatments—alongside healthy control subjects. The research assessed how the drug’s exposure relates to its effects in the brain, demonstrating a significant increase in both survival (22%; 26 days) and assessments of movement and behavior at 16 weeks versus un
Galderma Announces Triple Approval of New State-of-the-Art Restylane ® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane products in multiple facial indications including the cheeks, nose, chin, jawline, tear troughs, nasolabial folds, marionette lines, as well as in the hands.1-3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224651688/en/ The syringe features a next-generation ergonomic design that enhances precision and control; includes an optimized syringe-needle connection with the new Terumo K-Pack Enhance™ needle; and offers a premium color-coded packaging and syringe design to support easy range navigation for practitioners.4-7, 9,10 It sets a new standard in Injectable Aesthetic devices and demonstrates Galderma’s unwavering commitment to driving innovation to meet the needs of both practitioners and patients. “Developing this new syringe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom